Skip to content
Review

Environmental Risk Assessment in Pharmaceutical Regulation: A Comparative Review of EMA, U.S. FDA and CDSCO Guidelines.

Sep 2026 · Therapeutic Innovation and Regulatory Science · 0 citations · 38 references
Medicine

TL;DR

Regulatory gaps, mainly in India, and possibilities for harmonised ERA frameworks that can safeguard global health and biodiversity by encouraging regulatory consolidation are discovered by this study.

View source

Similar papers

Review Open access Aug 2026

Approaches to assessing the environmental impact of pharmaceuticals (review)

A comparative analysis of environmental risk assessment methods used in the European Union, United States, and Russia is conducted to conduct a comparative analysis of modern approaches to assessing the impact of drugs on the environment in various regulatory systems.

A. V. Golovin, N. Pyatigorskaya, S. А. Loseva et al. · 0 citations
Review Open access 2026

CHALLENGES OF PHARMACEUTICAL POLLUTANTS: ENVIRONMENTAL IMPACT, LIFE-CYCLE CONCERNS, AND SAFETY STRATEGIES FOR SUSTAINABLE DRUG MANAGEMENT

This study reviews the sources, fate, and impacts of pharmaceutical contaminants, emphasizing both conventional and modern drugs, including expired medications, and highlights the challenges associated with inadequate regulatory frameworks, limited public awareness, and inefficiencies in existing treatment technologies...

Santosh Kumar · 0 citations
Open access Sep 2026

Regulatory Trends and Challenges in Pharmaceutical Submissions: A Critical Analysis of Health Authority Requirements on Nitrosamine Impurities, Elemental Impurities, Forced Degradation and Genotoxicity

Comparing regulatory anticipations of impurity management within pharmaceutical submissions in terms of elements of nitrosamine impurities, genotoxic impurities, forced degradation, and elemental impurities shows that the compliance with harmonized ICH requirements and regulatory frameworks allows managing impurities r...

Darshan Mistry, Zuki Patel, Vinit Movaliya et al. · 0 citations
Open access Sep 2026

Effects of Improper Disposal of Expired and Unused Pharmaceutical Products on Man and the Environment

The improper disposal of expired and unused pharmaceutical products has become something of great public health and environmental concern worldwide. This study examines the pathways through which pharmaceuticals enter the environment, including household waste, sewage systems, and landfill leachates, and assess thei...

Yinka Akinade · 0 citations
Review Open access Aug 2026

Biomedical waste management in veterinary medicine and its impact on the environment: A comprehensive review.

Biomedical waste (BMW) management is a crucial aspect of both human and veterinary healthcare to prevent environmental contamination and transmission of infectious diseases. Veterinary BMW, although often overlooked, comprises hazardous materials such as infectious waste, sharps, pharmaceuticals, chemicals, radioactive...

Vaishali Sehrawat, Mohit Kumar, G. N. Aderao et al. · 0 citations
Open access Aug 2026

LOST IN DEFINITION: THE LEGAL STATUS OF PHARMACEUTICAL WASTE IN EU LAW

It is argued that current EU law lacks a coherent concept of pharmaceutical waste capable of addressing the increasing environmental risks associated with active pharmaceutical ingredients (APIs), and a proposal for a definition of pharmaceutical waste is proposed.

Zofia Kołodziej · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.